[Concomitant impairments of essential fatty acids and endothelium-dependent vasodilation in the pathogenesis of arterial hypertension and atherosclerosis].
Titov
V N
VN
D000375:Aging / Q000378:metabolism; D000818:Animals; D050197:Atherosclerosis / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D002462:Cell Membrane / Q000378:metabolism; D004195:Disease Models, Animal; D004730:Endothelium, Vascular / Q000378:metabolism / Q000503:physiopathology; D005228:Fatty Acids, Essential / Q000096:biosynthesis* / Q000378:metabolism; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D008563:Membrane Lipids / Q000096:biosynthesis / Q000378:metabolism; D009504:Neutrophils / Q000378:metabolism; D051381:Rats; D011918:Rats, Inbred SHR; D013045:Species Specificity; D014664:Vasodilation / Q000187:drug effects / Q000502:physiology*
D005228:Fatty Acids, Essential; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008563:Membrane Lipids